JBI Evidence Synthesis is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the field of evidence-based practice in nursing. With an impressive Q1 ranking in the 2023 category of Nursing (Miscellaneous) and holding the rank of #25 out of 139 in General Nursing according to Scopus, this journal serves as a key resource for researchers, practitioners, and students alike. Its focus on synthesizing high-quality research evidence allows for the integration of best practices into clinical settings, thereby enhancing patient care and health outcomes. Since its inception, JBI Evidence Synthesis has been committed to promoting rigorous methodologies and innovative approaches in evidence synthesis, making it an essential publication for anyone seeking to contribute to the advancement of nursing and healthcare. The journal is available in both print and online formats, ensuring wide accessibility to critical knowledge in the field.

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Advanced Emergency Nursing Journal, published by Lippincott Williams & Wilkins, stands as a key resource within the domains of Emergency Medicine and Emergency Nursing. With a commitment to advancing the field, this journal provides a platform for rigorous research, critical reviews, and innovative practices aimed at enhancing patient care in emergency settings. Though it holds a Q3 ranking in both related categories as per the 2023 metrics, its global reach spans various aspects of emergency care, promising insights that are crucial for both professionals and academics alike. Covering topics from clinical procedures to policy analysis, the journal invites submissions that aim to bridge theory and practice, highlighting the importance of evidence-based approaches in emergency nursing. Researchers, educators, and healthcare practitioners can Find more information and explore their own contributions in a dynamic environment that continuously evolves with the field. Whether you're seeking to stay current with the latest advancements or to publish your findings, this journal is an essential asset for those dedicated to improving care in urgent medical situations.

BMJ Evidence-Based Medicine is a premier journal published by BMJ Publishing Group that focuses on the critical appraisal and application of scientific evidence in clinical practice. With its ISSN 2515-446X and E-ISSN 2515-4478, this impactful journal operates out of the United Kingdom and has established itself as a leading resource in the field of evidence-based medicine, reflected by its impressive Q1 ranking in the Medicine (miscellaneous) category and a significant 93rd percentile ranking amongst General Medicine titles on Scopus. Offering an essential platform for researchers, practitioners, and students alike, the journal disseminates high-quality research and reviews that significantly influence healthcare practices worldwide. The journal currently has access options available for readers through institutional subscriptions and individual licenses, making cutting-edge research easily accessible to those dedicated to advancing medical knowledge. With its commitment to evidence-based practice, BMJ Evidence-Based Medicine plays a crucial role in improving patient outcomes and informing clinical decisions.

Circulation-Cardiovascular Quality and Outcomes, published by LIPPINCOTT WILLIAMS & WILKINS, stands as a leading journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and ranking in the Q1 category for both Cardiology and Cardiovascular Medicine, as well as in the broader field of Medicine (miscellaneous) as of 2023. With a dedicated focus on enhancing cardiovascular health through high-quality research, this journal disseminates vital findings that address clinical practice, healthcare delivery, and policy improvements. Operating under a rigorous peer-review process, it offers a platform for innovative studies and evidence-based insights essential for researchers, healthcare professionals, and students committed to advancing cardiovascular care. Although not an open-access journal, its contributions are invaluable to the ongoing dialogue within the medical community, driving essential changes and advancements in cardiovascular outcomes.

Enfermeria Clinica is a distinguished journal published by Elsevier España SLU, dedicated to advancing the field of nursing through robust scholarly research and clinical practice. With an ISSN of 1130-8621 and E-ISSN of 1579-2013, this esteemed journal serves as a vital resource for nurses, healthcare professionals, and researchers. Operating from Spain, it has established a reputation for excellence, notably achieving Q3 ranking in the categories of Fundamentals and Skills, Nursing (miscellaneous), and Research and Theory in 2023, indicating a solid influence within the academic community. The journal is devoted to disseminating innovative research that informs nursing practices and improves patient care. Although it operates on a subscription basis, the insights and findings published in Enfermeria Clinica are invaluable for those looking to enhance their knowledge in nursing evidenced-based practice. The journal’s commitment to bridging research with real-world application makes it an essential tool for both emerging and established professionals in the nursing field.

BMJ-British Medical Journal, published by the esteemed BMJ PUBLISHING GROUP, is a leading academic journal in the field of medicine, specifically categorized within the top Tier Q1 in Medicine (miscellaneous) based on the 2023 rankings. Recognized for its significant impact, BMJ holds an impressive rank of #15 out of 636 in General Medicine, placing it in the 97th percentile among its peers. With a legacy dating back to 1857, this journal continues to foster critical discussions and disseminate high-quality research aimed at advancing clinical practice and healthcare policy. While currently not an open-access journal, its rigorous peer-review process ensures that every publication meets the highest standards of scientific integrity and relevance. Situated in the heart of London at the British Medical Association House, the BMJ remains an essential resource for researchers, healthcare professionals, and students alike, dedicated to sharing impactful findings and innovative medical insights.

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.